. . . . . . . "MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist"@en . . . . "klinisch onderzoek"@nl . . . . . . . "A Phase III, Double-blind, Placebo-controlled Randomised Trial to Determine the Efficacy and Safety of a Low (50 mg/Day) and High (100 mg/Day) Dose of Safinamide, as add-on Therapy, in Subjects With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist"@en . . "MOTION"@en . . . . . . . . . . . . "MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist"@en . . . . . . . . . . . . . "2012-01-01T00:00:00Z"^^ . . . "NCT00605683" . . . . "30"^^ . "\u056F\u056C\u056B\u0576\u056B\u056F\u0561\u056F\u0561\u0576 \u0583\u0578\u0580\u0571\u0561\u0580\u056F\u0578\u0582\u0574"@hy . . . . . . . . . . . "80"^^ . . . "2007-11-01T00:00:00Z"^^ . . . . . . . . . . . . . . . "679"^^ . . . . . . . . "clinical trial"@en . . "MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist"@en . . . . . . . . . . . . . . . . . . . "ensayu cl\u00EDnicu"@ast . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . . . . . .